相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fetal therapies and trials for lysosomal storage diseases: a survey of attitudes of parents and patients
Marisa E. Schwab et al.
ORPHANET JOURNAL OF RARE DISEASES (2022)
Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI-FDA Meeting)
Akos Herzeg et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2022)
The rapidly evolving view of lysosomal storage diseases
Giancarlo Parenti et al.
EMBO MOLECULAR MEDICINE (2021)
Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction
Cindy Li et al.
GENETICS IN MEDICINE (2021)
Lysosomal storage disorders as an etiology of nonimmune hydrops fetalis: A systematic review
Neel S. Iyer et al.
CLINICAL GENETICS (2021)
Lysosomal storage disease spectrum in nonimmune hydrops fetalis: a retrospective case control study
Huda B. Al-Kouatly et al.
PRENATAL DIAGNOSIS (2020)
Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with Mucopolysaccharidosis type VII
Quoc-Hung Nguyen et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort
Ankit K. Desai et al.
FRONTIERS IN IMMUNOLOGY (2020)
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
Karolina M. Stepien et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement
Rachel Sagar et al.
MOLECULAR THERAPY (2020)
Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure
Yan Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Regulation and Function of Mitochondria-Lysosome Membrane Contact Sites in Cellular Homeostasis
Yvette C. Wong et al.
TRENDS IN CELL BIOLOGY (2019)
Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
Michael H. Gelb et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2019)
Infantile onset Pompe disease presenting with non-immune hydrops fetalis
Kristen Lee et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2019)
Pompe Disease: From Basic Science to Therapy
Lara Kohler et al.
NEUROTHERAPEUTICS (2018)
Lysosomal storage diseases
Frances M. Platt et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Review: The blood-brain barrier; protecting the developing fetal brain
Kate Goasdoue et al.
PLACENTA (2017)
Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures
C. Zwiers et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control
Roberta Haddad-Tovolli et al.
FRONTIERS IN NEUROSCIENCE (2017)
Sustained immune tolerance induction in enzyme replacement therapy-treated CRIM-negative patients with infantile Pompe disease
Zoheb B. Kazi et al.
JCI INSIGHT (2017)
Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction
Priya S. Kishnani et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Etiology of Non-Immune Hydrops Fetalis: An Update
Carlo Bellini et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
Lysosomal storage disease as an etiology of nonimmune hydrops
Alexis C. Gimovsky et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #7: nonimmune hydrops fetalis
Mary E. Norton et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
The many faces of hydrops
S. Christopher Derderian et al.
JOURNAL OF PEDIATRIC SURGERY (2015)
Immune tolerance strategies in siblings with infantile Pompe disease - Advantages for a preemptive approach to high-sustained antibody titers
Elizabeth O. Stenger et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2015)
Intrauterine Blood Transfusion: Current Indications and Associated Risks
Irene T. M. Lindenburg et al.
FETAL DIAGNOSIS AND THERAPY (2014)
Sphingolipid lysosomal storage disorders
Frances M. Platt
NATURE (2014)
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
Priya S. Kishnani et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Oxidative Stress and Autophagy in the Regulation of Lysosome-Dependent Neuron Death
Violetta N. Pivtoraiko et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
When more is less Excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease
Nina Raben et al.
AUTOPHAGY (2009)
Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero
Jeff E. Mold et al.
SCIENCE (2008)
Sibling phenotype concordance in classical infantile Pompe disease
Wendy E. Smith et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Pompe disease diagnosis and management guideline
Priya S. Kishnani et al.
GENETICS IN MEDICINE (2006)
Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization
IL van Kamp et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Investigation of lysosomal storage diseases in nonimmune hydrops fetalis
MG Burin et al.
PRENATAL DIAGNOSIS (2004)
Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment
K Sohan et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2001)
Evaluation of fetal heart dimensions from 12 weeks to term
C Firpo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)